Compare GFF & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFF | RLAY |
|---|---|---|
| Founded | 1959 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.1B |
| IPO Year | 1994 | 2020 |
| Metric | GFF | RLAY |
|---|---|---|
| Price | $91.56 | $20.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $105.00 | $19.50 |
| AVG Volume (30 Days) | 379.1K | ★ 4.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.99% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $2,519,926,000.00 | $15,355,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $324.03 |
| P/E Ratio | $50.09 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $65.01 | $3.03 |
| 52 Week High | $98.37 | $20.79 |
| Indicator | GFF | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 72.20 |
| Support Level | $88.17 | $12.10 |
| Resistance Level | $96.58 | N/A |
| Average True Range (ATR) | 3.05 | 1.24 |
| MACD | -0.59 | 0.21 |
| Stochastic Oscillator | 34.82 | 98.78 |
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.